Skip to main content
    P

    Pro-Dex Inc (PDEX)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $61.93
    -2.55 (-3.95%)

    Market Cap: $210.11M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Pro-Dex Inc (PDEX) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Pro-Dex (PDEX) has a market cap of $210.11M and an enterprise value of $219.39M. Its return on invested capital of 18.98% compares with a 3.12% median across 6 similar companies.

    Total Valuation

    Enterprise value is 4.42% above the market cap, as debt exceeds cash.

    Market Cap$210.11M
    Enterprise Value$219.39M
    Latest price (Nov 17, 2026)$61.93

    Key Dates

    The next earnings report is expected on Jan 27, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateJan 27, 2027 (expected)
    Last Earnings DateOct 29, 2026
    Fiscal Year EndJune

    Share Statistics

    The share count fell 1.47% in the quarter ended Mar 31, 2026 and shrank 3.69% a year over 2 years.

    Shares Outstanding3.23M
    Shares Change (YoY)-1.83%
    Shares Change (QoQ)-1.47%
    Share Count Growth (2Y CAGR)-3.69%

    Valuation Ratios

    Sales and book value multiples are 2.6x and 4.2x. Its year-end P/E ranged from 4.8x to 23.4x from 2016 to 2025.

    P/E Ratio17.0x
    Forward P/E19.6x
    P/S Ratio2.6x
    Forward P/S2.5x
    P/B Ratio4.2x
    P/TBV Ratio4.9x
    P/FCF Ratio29.6x
    P/OCF Ratio29.0x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 11.8x EBITDA and 30.9x free cash flow.

    EV / Earnings16.1x
    EV / Sales2.8x
    EV / EBITDA11.8x
    EV / FCF30.9x

    Price Statistics

    The stock is up 92.99% over 52 weeks and trades 4.38% below its 50-day average.

    Beta (1Y)1.25
    52-Week Change+92.99%
    1-Month Change+7.33%
    3-Month Change-7.48%
    6-Month Change+1.89%
    5-Year Change+139.64%
    10-Year Change+1150.75%
    Total Return (1Y)+92.99%
    Total Return (3Y CAGR)+53.55%
    Total Return (5Y CAGR)+24.73%
    Return vs SPY (1Y)+92.56%
    Max Drawdown (1Y)-21.47%
    Max Drawdown (3Y)-65.36%
    Sharpe Ratio (1Y)1.30
    Correlation with SPY (1Y)0.31
    50-Day Average$64.77
    200-Day Average$58.01
    52-Week Range$28.81 to $77.00
    RSI (14 Days)45.9
    Average Volume (20 Days)38.42K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 4.10x current liabilities, and total debt is 0.37x shareholder equity.

    Current Ratio4.10x
    Quick Ratio2.45x
    Debt / Equity0.37x
    Debt / EBITDA0.99x
    Debt / FCF2.58x
    Interest Coverage20.06x

    Returns and Efficiency

    Return on invested capital is 18.98% over the last 12 months, against a 5-year average of 13.00%.

    Return on Equity (ROE)28.68%
    Return on Assets (ROA)18.34%
    Return on Invested Capital (ROIC)18.98%
    ROE (5Y Average)20.09%
    ROA (5Y Average)12.01%
    ROIC (5Y Average)13.00%
    Asset Turnover1.14x
    Inventory Turnover2.43x
    Receivables Turnover3.81x
    Cash Conversion Cycle213 days

    Taxes

    Income tax took 24.16% of pretax income over the last 12 months.

    Income Tax (TTM)$4.35M
    Effective Tax Rate24.16%

    Scores

    PDEX has an Altman Z-Score of 7.77, in the safe zone above 2.99, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.

    Altman Z-Score7.77
    Altman Z ZoneSafe
    Piotroski F-Score6 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $77.55M over the last 12 months is up 16.45% from the 12 months before.

    Revenue$77.55M
    Revenue Growth (YoY)+16.45%
    Gross Profit$24.34M
    Operating Income$12.99M
    Pretax Income$18.02M
    Net Income$13.66M
    Reported EPS (TTM)$3.65

    Trailing 12 months through Jun 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 63.92% of the $74.51M in total assets.

    Cash and Equivalents$8.19M
    Total Debt$17.47M
    Net Debt$9.28M
    Net Debt Per Share$2.88
    Working Capital$40.27M
    Shareholder Equity$47.63M
    Book Value Per Share$14.77
    Tangible Book Value$40.42M
    Tangible Book Per Share$12.53
    Total Assets$74.51M
    Total Liabilities$26.88M

    Balance sheet as of Jun 30, 2026.

    Full balance sheet

    Cash Flow

    After $483.00K of capital spending, operating cash flow left $6.76M of free cash flow.

    Operating Cash Flow$7.24M
    Capital Expenditures$483.00K
    Free Cash Flow$6.76M
    FCF Per Share$2.11
    Depreciation and Amortization$1.48M
    Share Repurchases$3.41M

    Trailing 12 months through Jun 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 16.75%, against a 5-year average of 14.16%.

    Gross Margin31.38%
    Operating Margin16.75%
    Pretax Margin23.23%
    Net Margin17.62%
    FCF Margin8.72%
    Gross Margin (5Y Average)29.32%
    Operating Margin (5Y Average)14.16%
    Net Margin (5Y Average)12.25%

    Growth

    Revenue grew 18.94% a year over 3 years, and EPS 46.65% a year.

    Revenue Growth (3Y CAGR)+18.94%
    Revenue Growth (5Y CAGR)+15.32%
    EPS Growth (3Y CAGR)+46.65%
    EPS Growth (5Y CAGR)+29.83%
    FCF Growth (3Y CAGR)+14.62%
    Operating Income Growth (3Y CAGR)+31.13%
    Book Value Per Share Growth (2Y CAGR)+10.77%
    Tangible Book Per Share Growth (2Y CAGR)+10.88%

    Revenue and profit by year

    Dividends and Yields

    PDEX does not pay a dividend. Its free cash flow yield is 3.38%.

    Earnings Yield5.88%
    FCF Yield3.38%
    Buyback Yield1.66%
    Shareholder Yield1.66%

    Stock Splits

    The last split was a 1-for-3 reverse split on Jun 18, 2010.

    Last Split DateJun 18, 2010
    Split TypeReverse split
    Split Ratio1:3

    Peer Position

    Against 3 similar companies, PDEX has the 3rd highest P/E.

    P/E Ratio17.0x vs 21.6x median
    P/S Ratio2.6x vs 2.6x median
    ROIC18.98% vs 3.12% median
    Revenue Growth (Trailing 4 Quarters, YoY)+16.45% vs +6.52% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 5.80% and EPS growth at -9.82% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+5.80%
    EPS Growth Forecast (2Y CAGR)-9.82%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About PDEX

    What is PDEX's market cap?

    Pro-Dex has a market cap of $210.11M. Its enterprise value, which adds debt and subtracts cash, is $219.39M.

    What is PDEX's P/E ratio?

    Pro-Dex has a trailing P/E ratio of 17.0x and a forward P/E of 19.6x.

    How many shares of PDEX are outstanding?

    Pro-Dex has 3.23M shares outstanding. The count is down 1.83% from a year earlier.

    Does PDEX pay a dividend?

    No. Pro-Dex does not pay a dividend.

    How much debt does PDEX have?

    Pro-Dex has $17.47M of total debt and $8.19M of cash and equivalents, a net debt position of $9.28M.